Radiation treatment planning firm CMS of St. Louis has applied to the U.S. Food and Drug Administration (FDA) for 510(k) clearance of its CMS Atlas-Based Autosegmentation software.
CMS Atlas-Based Autosegmentation is designed to produce estimates of anatomy boundary contours to create a radiotherapy treatment plan (RTP). The program communicates with radiotherapy planning programs via DICOM-format data.
Atlas-Based Autosegmentation uses deformable registration to match the atlas image to corresponding points in a patient image. The atlas contours are then mapped onto the patient using that deformation.
Related Reading
Elekta completes CMS purchase, March 5, 2008
Elekta to buy CMS, February 19, 2008
CMS nets FDA OK for Monaco, October 16, 2007
CMS unveils deals, FDA submission, July 23 2007
CMS, Toshiba collaborate on Idaho installation, June 22, 2007
Copyright © 2008 AuntMinnie.com
